Search Within

OVARIAN CANCER
Results 1 - 224 of 224
Eliminating Ovarian Cancer Stem Cells: A Potential Therapeutic Target for Ovarian Cancer Chemoresistance

Journal: Current Protein & Peptide Science
Volume: 16,Issue: 4
Page: 270-278
Authors: Xiaohui Wang, Xiaolei Li, Xiaoyu Fu, Miaomiao Bai, Xiang Li, Qian Mei, Jing Nie, Zhiqiang Wu and Weidong Han

Psychological Sequelae of Ovarian Cancer Screening and Genetic Testing for Ovarian Cancer Susceptibility

Journal: Current Women`s Health Reviews
Volume: 7,Issue: 4
Page: 358-366
Authors: A. Fuchsia Howard, Marie Pirotta and Lynda G. Balneaves

Gene Directed Enzyme Prodrug Therapy for Ovarian Cancer: Could GDEPT Become a Promising Treatment Against Ovarian Cancer?

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 8,Issue: 2
Page: 232-239
Authors: Akihiro Nawa, Tadatoshi Tanino, Chen Hong Luo, Masahiro Iwaki, Hiroaki Kajiyama, Kiyosumi Shibata, Eiko Yamamoto, Kazuhiko Ino, Yukihiro Nishiyama and Fumitaka Kikkawa

Stress Related Neuroendocrine Influences in Ovarian Cancer

Journal: Current Cancer Therapy Reviews
Volume: 8,Issue: 2
Page: 100-109
Authors: Yu Kang, Susan K. Lutgendorf, Wei Hu, Steven W. Cole and Anil K. Sood

Antigen-specific Immunotherapy in Ovarian Cancer and p53 as Tumor Antigen

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 25
Page: 3804-3811
Authors: Renee Vermeij, Ninke Leffers, Cornelis J. Melief, Toos Daemen and Hans W. Nijman

Angiogenesis and Anti-angiogenic Therapies in Epithelial Ovarian Cancer

Journal: Current Angiogenesis (Discontinued)
Volume: 3,Issue: 2
Page: 60-65
Authors: Halima Abahssain, Sakina Sekkate, Sihame Lkhoyaali, Patricia Pautier, Hind M’Rabti and Hassan Errihani

Ovarian Cancer Biomarkers: A Focus on Genomic and Proteomic Findings

Journal: Current Genomics
Volume: 8,Issue: 5
Page: 335-342
Authors: Andrea Tinelli, Daniele Vergara, Roberta Martignago, Giuseppe Leo, Antonio Malvasi, Raffaele Tinelli, Santo Marsigliante, Michele Maffia and Vito Lorusso

HGF/MET Signaling in Ovarian Cancer

Journal: Current Molecular Medicine
Volume: 8,Issue: 6
Page: 469-480
Authors: Hong Yan Zhou, Yuen Lam Pon and Alice S.T. Wong

Oncogenic MicroRNA-27a is a Target for Genistein in Ovarian Cancer Cells

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13,Issue: 7
Page: 1126-1132
Authors: Linlin Xu, Jingying Xiang, Jian Shen, Xi Zou, Sulan Zhai, Yongxiang Yin, Ping Li, Xuerong Wang and Qingmin Sun

Novel Therapeutic Strategies For Angiogenesis Inhibition In Recurrent Ovarian Cancer

Journal: Current Angiogenesis (Discontinued)
Volume: 3,Issue: 4
Page: 179-192
Authors: Victoria L. Chiou, Elise C. Kohn, Nicole Davarpanah and Jung-Min Lee

Targeting mTOR Signaling Pathway in Ovarian Cancer

Journal: Current Medicinal Chemistry
Volume: 18,Issue: 19
Page: 2960-2968
Authors: S. Mabuchi, T. Hisamatsu and T. Kimura

The Role of Bevacizumab in Advanced Epithelial Ovarian Cancer

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 25
Page: 3775-3783
Authors: Judith R. Kroep and Johan W.R. Nortier

Epithelial Mesenchymal Transition and Cancer Stem Cell-Like Phenotypes Facilitate Chemoresistance in Recurrent Ovarian Cancer

Journal: Current Cancer Drug Targets
Volume: 10,Issue: 3
Page: 268-278
Authors: N. Ahmed, K. Abubaker, J. Findlay and M. Quinn

Targeting Ovarian Cancer-Initiating Cells

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 10,Issue: 2
Page: 157-163
Authors: Susan K. Murphy

Interleukin-6/interleukin-6 Receptor Pathway as a New Therapy Target in Epithelial Ovarian Cancer

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 25
Page: 3816-3827
Authors: Eveline M. Dijkgraaf, Marij J.P. Welters, Johan W.R. Nortier, Sjoerd H. van der Burg and Judith R. Kroep

MMPs in Ovarian Cancer as Therapeutic Targets

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12,Issue: 7
Page: 764-772
Authors: Amer Karam and Oliver Dorigo

MicroRNAs as Diagnostic, Prognostic and Predictive Biomarkers of Ovarian Cancer

Journal: Recent Patents on Biomarkers
Volume: 3,Issue: 2
Page: 120-136
Authors: Corey L. Neal, Jian-peng Teoh, Yaoping Tang, Yongchao Wang, Kyoung-mi Park and Il-man Kim

Potential Use of Drug Loaded Nano Composite Pectin Scaffolds for the Treatment of Ovarian Cancer

Journal: Current Drug Delivery
Volume: 10,Issue: 3
Page: 326-335
Authors: Sarika Chandran, G. Praveen, K.S. Snima, Shantikumar V. Nair, K. Pavithran, Krishnaprasad Chennazhi and Vinoth-Kumar Lakshmanan

Recent Patents for Homologous Recombination Deficiency Assays Among Women with Ovarian Cancer

Journal: Recent Patents on Biotechnology
Volume: 9,Issue: 2
Page: 86-101
Authors: Christopher J. LaFargue and Krishnansu S. Tewari

Association between MTHFR Gene Polymorphism and the Risk of Ovarian Cancer: A Meta-analysis of the Literature

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 11
Page: 1632-1638
Authors: Danhua Pu, Shi-Wen Jiang and Jie Wu

Cellular Therapy for Ovarian Cancer: Experimental and Clinical Perspectives

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 22
Page: 3787-3793
Authors: Susan B. Ingersoll, Sarfraz Ahmad, Neil J. Finkler, John R. Edwards and Robert W. Holloway

Survival Benefit of Adding Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) at the Different Time-points of Treatment of Ovarian Cancer: Review of Evidence

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 25
Page: 3793-3803
Authors: Stefaan Mulier, Jean-Pierre Claes, Vincent Dierieck, Jean-Olivier Amiel, Jean-Philippe Pahaut, Luc Marcelis, Fabienne Bastin, Denis Vanderbeeken, Claude Finet, Sophie Cran and Thierry Velu

The Benefits and Side Effects of Bevacizumab for the Treatment of Recurrent Ovarian Cancer

Journal: Current Drug Targets
Volume: 18,Issue: 10
Page: 1125-1131
Authors: Wenwen Zhang, Zhaojun Shen, Hui Luo, Xiaoli Hu, Lihong Zheng and Xueqiong Zhu*

Targeting Platinum Resistant Disease in Ovarian Cancer

Journal: Current Medicinal Chemistry
Volume: 21,Issue: 26
Page: 3009-3020
Authors: S.L. Morgan, J.E. Medina, M.M. Taylor and D.M. Dinulescu

Immune Checkpoint Inhibition: Therapeutic Implications in Epithelial Ovarian Cancer

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 10,Issue: 2
Page: 133-144
Authors: Teresa C. Longoria and Ramez N. Eskander

Targeted Therapy of Ovarian Cancer with Angiogenesis Inhibitors

Journal: Current Drug Targets
Volume: 18,Issue: 10
Page: 1171-1178
Authors: Ping Duan, Lili Fan, Quansheng Gao, Bal Mukunda Silwal, Mulan Ren, Yang Shen* and Wanglei Qu*

Effective Strategies and Applications of Dendrimers in the Treatment of Ovarian Cancer

Journal: Current Pharmaceutical Design
Volume: 23,Issue: 21
Page: 3099-3104
Authors: Akila Kesavan, Suresh Babu Pakala, Suresh K. Rayala* and Ganesh Venkatraman*

Targeted Gene Therapy for Ovarian Cancer

Journal: Current Gene Therapy
Volume: 5,Issue: 6
Page: 643-653
Authors: Rodney P. Rocconi, T. M. Numnum, Mariam Stoff-Khalili, Sharmila Makhija, Ronald D. Alvarez and David T. Curiel

The Epithelial-Mesenchymal Transition and the Estrogen-Signaling in Ovarian Cancer

Journal: Current Drug Targets
Volume: 11,Issue: 4
Page: 474-481
Authors: D. Gallo, C. Ferlini and G. Scambia

Inhibitory Effects of Bisphosphonates on the Proliferation of Human Ovarian Cancer Cell Lines and the Mechanism

Journal: Medicinal Chemistry
Volume: 2,Issue: 3
Page: 223-226
Authors: Hiroshi Seto, Tsunekazu Kita, Junko Hirata, Yoshihiro Kikuchi and Kazuya Kudoh

Intraperitoneal Chemotherapy as First-Line Treatment in the Management of Epithelial Ovarian Cancer

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 7,Issue: 5
Page: 511-519
Authors: S. Rekhraj, J. Kinross, S. Prabhudesai, A. Darzi and P. Ziprin

Patented Biomarkers for the Early Detection of Ovarian Cancer

Journal: Recent Patents on Biomarkers
Volume: 1,Issue: 1
Page: 1-9
Authors: Roberta Veneroni, Claudia Peracchio, Roberta Castino and Ciro Isidoro

Review of Dose-intense Platinum and/or Paclitaxel Containing Chemotherapy in Advanced and Recurrent Epithelial Ovarian Cancer

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 25
Page: 3741-3753
Authors: Ingrid A. Boere and Maria E.L. van der Burg

DIMming Ovarian Cancer Growth

Journal: Current Drug Targets
Volume: 13,Issue: 14
Page: 1869-1875
Authors: Prabodh K. Kandala and Sanjay K. Srivastava

TNFR1 Regulates Ovarian Cancer Cell Tumorigenicity Through PIK3CB-p110Beta

Journal: Current Molecular Medicine
Volume: 15,Issue: 5
Page: 487-496
Authors: C. Peng, J. Su, W. Zeng, X. Zhang and X. Chen

Management of Ovarian Cancer in Elderly

Journal: Reviews on Recent Clinical Trials
Volume: 10,Issue: 4
Page: 270-275
Authors: Sushil K. Giri and Bhagyalaxmi Nayak

Ribosome Display and Selection of Human Anti-Placental Growth Factor scFv Derived from Ovarian Cancer Patients

Journal: Protein & Peptide Letters
Volume: 17,Issue: 5
Page: 585-590
Authors: Fang Li, Pingping Su, Chao Lin, Hong Li, Jiajing Cheng and Donglu Shi

Mechanisms and Therapeutic Targets of microRNA-associated Chemoresistance in Epithelial Ovarian Cancer

Journal: Current Cancer Drug Targets
Volume: 16,Issue: 5
Page: 429-441
Authors: Lingyun Zhang, Lubna Nadeem, Kristin Connor and Guoxiong Xu

Vitamin D Receptor is a Novel Drug Target for Ovarian Cancer Treatment

Journal: Current Cancer Drug Targets
Volume: 6,Issue: 3
Page: 229-244
Authors: Xiaohui Zhang, Santo V. Nicosia and Wenlong Bai

Co-targeting EGFR and Autophagy Impairs Ovarian Cancer Cell Survival during Detachment from the ECM

Journal: Current Cancer Drug Targets
Volume: 15,Issue: 3
Page: 215-226
Authors: Zongyuan Yang, Yi Liu, Xiao Wei, Xiaoshui Zhou, Cheng Gong, Taoran Zhang, Ping Jin, Sen Xu, Ding Ma and Qinglei Gao

Molecular Mechanisms and Potential Treatment Targets for Ovarian Cancer by Analyzing Transcriptional Regulatory Network

Journal: Letters in Drug Design & Discovery
Volume: 14,Issue: 1
Page: 112-118
Authors: Fei Wu, Xinrui Liu, Yujie Sui, Tianmin Xu and Manhua Cui

Incorporation of Anti-angiogenic Therapies in the Treatment of Epithelial Ovarian Cancer: Current Perspectives and Future Directions

Journal: Current Angiogenesis (Discontinued)
Volume: 1,Issue: 4
Page: 266-276
Authors: Ramez N. Eskander and Philip J. DiSaia

Role of Integrated 18-F FDG PET/CT in Recurrent Ovarian Cancer

Journal: Current Medical Imaging Reviews
Volume: 1,Issue: 1
Page: 1-4
Authors: Sandro Sironi, Cristina Messa and Ferruccio Fazio

The Biphasic Expression Pattern of miR-200a and E-cadherin in Epithelial Ovarian Cancer and its Correlation with Clinicopathological Features

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 11
Page: 1888-1895
Authors: Shaohua Xu, Peizhen Xu, Wei Wu, Yangjun Ou, Juan Xu, Guanghua Zhang, Jinping Li and Guofeng Xu

Transcription Factor WT1 and Promoter CpG Hypomethylation Coactivate HOXA10 Expression in Ovarian Cancer

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 11
Page: 1647-1654
Authors: Yi Jiang, Yongli Chu, Weiwei Tang, Yicong Wan, Lin Zhang and Wenjun Cheng

Activation of Integrin β1 Mediates the Increased Malignant Potential of Ovarian Cancer Cells Exerted by Inflammatory Cytokines

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14,Issue: 7
Page: 955-962
Authors: Zongyuan Yang, Xiaoshui Zhou, Yi Liu, Cheng Gong, Xiao Wei, Taoran Zhang, Ding Ma and Qinglei Gao

Low Dose Decitabine Combined with Taxol and Platinum Chemotherapy to Treat Refractory/Recurrent Ovarian Cancer: An Open-Label, Single-Arm, Phase I/II Study

Journal: Current Protein & Peptide Science
Volume: 16,Issue: 4
Page: 329-336
Authors: Xiaoyu Fu, Yan Zhang, Xiaohui Wang, Meixia Chen, Yao Wang, Jing Nie, Yuanguang Meng and Weidong Han

Effects of CAP-regimen Chemotherapy on Blood Redox Status in Patients with Ovarian Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15,Issue: 9
Page: 1141-1147
Authors: Inna I. Antoneeva, Dinara R. Dolgova, Tatyana P. Gening, Tatyana V. Abakumova, Snezhanna O. Gening, Sabina S. Pirmamedova, Anastasia V. Fomina and Alla A. Mikheenko

Drug Discovery in Ovarian Cancer

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 5,Issue: 3
Page: 251-260
Authors: Dana M. Chase, Nidhee Mathur and Krishnansu S. Tewari

Intraperitoneal Chemotherapy as Primary Treatment of Advanced Ovarian Cancer:Efficacy, Toxicity, and Future Directions

Journal: Reviews on Recent Clinical Trials
Volume: 2,Issue: 3
Page: 169-173
Authors: Maurie Markman

Pharmacological Approaches for BRCA1/2 Related Breast and Ovarian Cancer: Preclinical Studies and Early Clinical Trials

Journal: Current Women`s Health Reviews
Volume: 8,Issue: 1
Page: 104-110
Authors: Pierosandro Tagliaferri, Monica Ventura, Iole Cucinotto, Maria Teresa Di Martino and Pierfrancesco Tassone

Human Endometrial and Ovarian Cancer Cells: Histone Deacetylase Inhibitors Exhibit Antiproliferative Activity, Potently Induce Cell Cycle Arrest, and Stimulate Apoptosis

Journal: Current Medicinal Chemistry
Volume: 14,Issue: 24
Page: 2548-2553
Authors: Noriyuki Takai, Hisashi Narahara, Noriyuki Takai and Hisashi Narahara

Proteolytic Enzymes and Their Inhibition in Epithelial Ovarian Cancer

Journal: Current Enzyme Inhibition
Volume: 1,Issue: 2
Page: 157-170
Authors: A. McDonnel Smedts, T. E. Curry Jr. and W. J. Murdoch

Long-Term Survival and Cost of Treatment in Patients with Stage IIIC Epithelial Ovarian Cancer

Journal: Current Women`s Health Reviews
Volume: 5,Issue: 1
Page: 44-50
Authors: Leniaud Louis, Sifer Christophe, Amy L. Cooper, David F. Nelson, Stacy Doran, Fred R. Ueland, Christopher P. DeSimone, Paul D. DePriest, John M. McDonald, Brook A. Saunders, Rachel A. Ware, Edward J. Pavlik, Richard J. Kryscio, Michael Karpf and John R. van Nagell Jr.

Targeting Pathways Contributing to Epithelial-Mesenchymal Transition (EMT) in Epithelial Ovarian Cancer

Journal: Current Drug Targets
Volume: 13,Issue: 13
Page: 1649-1653
Authors: Ruby Yun-Ju Huang, Vin Yee Chung and Jean Paul Thiery

TRPC Channels and Their Splice Variants are Essential for Promoting Human Ovarian Cancer Cell Proliferation and Tumorigenesis

Journal: Current Cancer Drug Targets
Volume: 13,Issue: 1
Page: 103-116
Authors: Bo Zeng, Cunzhong Yuan, Xingsheng Yang, Stephen L. Atkin and Shang-Zhong Xu

Valeriana jatamansi Constituent IVHD-valtrate As a Novel Therapeutic Agent to Human Ovarian Cancer: in vitro and in vivo Activities and Mechanisms

Journal: Current Cancer Drug Targets
Volume: 13,Issue: 4
Page: 472-483
Authors: Xiaoguang Li, Tao Chen, Sheng Lin, Jing Zhao, Peizhan Chen, Qian Ba, He Guo, Yanling Liu, Jingquan Li, Ruiai Chu, Lei Shan, Weidong Zhang and Hui Wang

Synthetic Naphthoflavonoids Showing Inhibitory Effects on Clonogenicity against Cisplatin-Resistant A2780/Cis Human Ovarian Cancer Cells

Journal: Letters in Drug Design & Discovery
Volume: 12,Issue: 8
Page: 628-639
Authors: Yearam Jung, Soon Young Shin, Yeonjoong Yong, Hyuk Yoon, Seunghyun Ahn, Hyeryoung Jung, Dongsoo Koh, Young Han Lee and Yoongho Lim

Anti-angiogenic Therapy and Induction of Blood Vessel Normalization in the Treatment of Ovarian Cancer

Journal: Current Angiogenesis (Discontinued)
Volume: 3,Issue: 4
Page: 203-214
Authors: Simone Ten Kortenaar, Jack Lawler and Jim Petrik

Modulation of intracellular pH in human ovarian cancer.

Journal: Current Molecular Medicine
Volume: 16,Issue: 1
Page: 23-32
Authors: C. Sanhueza, J. Araos, L. Naranjo, R. Villalobos, F. Westermeier, C. Salomon, A.R. Beltrán, M.A. Ramírez, J. Gutiérrez, F. Pardo, A. Leiva and L. Sobrevia

HDAC Inhibitor Oxamflatin Induces Morphological Changes and has Strong Cytostatic Effects in Ovarian Cancer Cell Lines

Journal: Current Molecular Medicine
Volume: 16,Issue: 3
Page: 232-242
Authors: Y.-L. Wang, H.-L. Liui, R.-G. Fu, Z.-W. Wang, H.-T. Ren, Z.-J. Dai, Y.-Y. Jing and Y. Li

Construction of an Anticancer Fusion Peptide (ACFP) Derived from Milk Proteins and an Assay of Anti-ovarian Cancer Cells in vitro

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17,Issue: 4
Page: 635-643
Authors: Juan Zhou, Xue Yang, Wenxiao Zhang, Jing Wang, Cai Wei, Fang Gu, Ting Lei and Yide Qin*

Berberine Exhibits Antitumor Effects in Human Ovarian Cancer Cells

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15,Issue: 4
Page: 511-516
Authors: Ping Jin, Chunjie Zhang and Na Li

PI3K/AKT/mTOR Inhibitors In Ovarian Cancer

Journal: Current Medicinal Chemistry
Volume: 17,Issue: 36
Page: 4433-4447
Authors: M. Mazzoletti and M. Broggini

Antiangiogenic Therapy and Ovarian Cancer

Journal: Current Women`s Health Reviews
Volume: 4,Issue: 1
Page: 33-44
Authors: Richard T. Penson, J. Alejandro Rauh-Hain and Neil S. Horowitz

Immunotherapy for Epithelial Ovarian Cancer - Immunological Background, Critical Review of Methods and Future Perspectives

Journal: Current Immunology Reviews
Volume: 6,Issue: 3
Page: 221-233
Authors: Jacek R. Wilczynski and Markus Duechler

Antiangiogenic Drugs in the Treatment of Advanced Epithelial Ovarian Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12,Issue: 8
Page: 982-987
Authors: Parham Khosravi-Shahi and Luis Cabezon-Gutierrez

Ovarian Cancer - Angiogenesis and Targeted Therapy

Journal: Current Angiogenesis (Discontinued)
Volume: 3,Issue: 4
Page: 215-230
Authors: Kristsanamon Rittiluechai, Naiyarat Prasongsuk, Vincent Vinh-Hung and Claire Verschraegen

Cytokine Status of Serum in Ovarian Cancer Patients with Different Tumor Neoadjuvant Chemotherapy Response

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17,Issue: 9
Page: 1251-1255
Authors: Inna I. Antoneeva, Tatyana V. Abakumova, Dinara R. Dolgova, Tatyana P. Gening*, Sabina S. Pirmamedova, Dinara F. Myasnikova and Snezhanna O. Gening

Gene Expression Profiling of Epithelial Ovarian Cancer

Journal: Current Genomics
Volume: 7,Issue: 2
Page: 115-135
Authors: Anette Sommer, Felix Hilpert and Norbert Arnold

Current Status of Primary Cytoreductive Surgery for the Treatment of Advanced Epithelial Ovarian Cancer

Journal: Current Cancer Therapy Reviews
Volume: 5,Issue: 1
Page: 67-79
Authors: Kaei Nasu, Harunobu Matsumoto, Noriyuki Takai and Hisashi Narahara

Trabectedin as a New Chemotherapy Option in the Treatment of Relapsed Platinum Sensitive Ovarian Cancer

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 25
Page: 3754-3769
Authors: Bradley J. Monk, Heather Dalton, Ivor Benjamin and Adnan Tanovic

Multiple VEGF Family Members are Simultaneously Expressed in Ovarian Cancer: a Proposed Model for Bevacizumab Resistance

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 25
Page: 3784-3792
Authors: Arne R.M. van der Bilt, Ate G.J. van der Zee, Elisabeth G.E. de Vries, Steven de Jong, Hetty Timmer- Bosscha, Klaske A. ten Hoor, Wilfred F.A. den Dunnen, Harry Hollema and Anna K.L. Reyners

Effect of Cytostatic Drugs on the mRNA Expression Levels of Ribonuclease κ in Breast and Ovarian Cancer Cells

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14,Issue: 3
Page: 400-408
Authors: Asimina S. Gkratsou, Emmanuel G. Fragoulis and Diamantis C. Sideris

Management of Ovarian Cancer In Younger Women

Journal: Reviews on Recent Clinical Trials
Volume: 10,Issue: 4
Page: 263-269
Authors: K. Uma Devi, N. Purushotham and N. Jayashree

Mitogen-activated Protein Kinase Kinase 6-fusion Protein (MAP2K6-FP) Potentiates the Anti-tumor effects of Paclitaxel in Ovarian Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15,Issue: 10
Page: 1308-1316
Authors: Jin Yuan, Jia-Li Kang, Hua Liao, Xiao-xia Wang, Miao-lin Nie, Rong Shuai and Cui Deng

Can the Status of the Breast and Ovarian Cancer Susceptibility Gene 1 Product (BRCA1) Predict Response to Taxane-Based Cancer Therapy?

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9,Issue: 5
Page: 543-549
Authors: J. Thomas DeLigio, Aneliya Velkova, Diego A.R. Zorio and Alvaro N.A. Monteiro

AP5346 (ProLindac™), A DACH Platinum Polymer Conjugate in Phase II Trials Against Ovarian Cancer

Journal: Current Bioactive Compounds
Volume: 7,Issue: 1
Page: 21-26
Authors: David P. Nowotnik

New Ultrasound-Based Technologies for Predicting Ovarian Cancer in Adnexal Masses

Journal: Current Women`s Health Reviews
Volume: 3,Issue: 2
Page: 89-94
Authors: Juan Luis Alcazar

Addressing the Challenge: Current and Future Directions in Ovarian Cancer Therapy

Journal: Current Gene Therapy
Volume: 9,Issue: 6
Page: 434-458
Authors: Tranum Kaur, Roderick A. Slavcev and Shawn D. Wettig

Targeted Alpha Therapy with 227Th-trastuzumab of Intraperitoneal Ovarian Cancer in Nude Mice

Journal: Current Radiopharmaceuticals
Volume: 6,Issue: 2
Page: 106-116
Authors: Helen Heyerdahl, Nasir Abbas, Kristine Sponheim, Camilla Mollatt, Oyvind Bruland and Jostein Dahle

Biomarkers for Systemic Therapy in Ovarian Cancer

Journal: Current Cancer Drug Targets
Volume: 14,Issue: 3
Page: 259-273
Authors: Zsofia Penzvalto, Pawel Surowiak and Balazs Gyorffy

Synthesis and Structure-activity Relationships of Chalcone Derivatives as Inhibitors of Ovarian Cancer Cell Growth

Journal: Letters in Drug Design & Discovery
Volume: 14,Issue: 11
Page: 1259-1266
Authors: Zachary D. Tucker, Francis J. Barrios and Amanda J. Krzysiak*

Exome Sequencing of Ovarian Cancer Patients to Identify Variants Predictive of Sensitivity to Platinum-based Chemotherapy

Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 14,Issue: 2
Page: 124-133
Authors: Assaad Y. Semaan, Kristin R. Delfino, Andrew C. Wilber, Thomas K. Mathews, Kathy J. Robinson, Laurent Brard and Shaheen R. Alanee*

Unmet Needs in Ovarian Cancer: Dividing Histologic Subtypes to Exploit Novel Targets and Pathways

Journal: Current Cancer Drug Targets
Volume: 13,Issue: 6
Page: 698-707
Authors: Vijaya Galic, Robert L. Coleman and Thomas J. Herzog

In Vitro High Throughput Phage Display Selection of Ovarian Cancer Avid Phage Clones for Near-Infrared Optical Imaging

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 17,Issue: 10
Page: 859-867
Authors: Mette Soendergaard, Jessica R. Newton-Northup and Susan L. Deutscher

Genetic Counseling for Hereditary Breast and Ovarian Cancer Among Puerto Rican Women Living in the United States

Journal: Reviews on Recent Clinical Trials
Volume: 9,Issue: 4
Page: 245-253
Authors: Courtney L. Scherr, Elsa Vasquez, Gwendolyn P. Quinn and Susan T. Vadaparampil

Trebananib (AMG 386): A Non-VEGF Antiangiogenesis Option in Women with Ovarian Cancer

Journal: Current Angiogenesis (Discontinued)
Volume: 3,Issue: 4
Page: 193-202
Authors: Al Wadi Khalid and Ghatage Prafull

Evaluation of a Genetic Counseling Aid for Hereditary Breast and Ovarian Cancer

Journal: Applied Clinical Research, Clinical Trials and Regulatory Affairs
Volume: 2,Issue: 2
Page: 103-109
Authors: Deborah Cragun, Lucia Camperlengo, Emily Robinson, Pauleena Pal, Jongphil Kim, Meghan Caldwell, Jennifer Brzosowicz, Courtney Lewis, Christina Bittner, Susan Vadaparampil and Tuya Pal

Patterns of Müllerian Inhibiting Substance Type II and Candidate Type I Receptors in Epithelial Ovarian Cancer†

Journal: Current Molecular Medicine
Volume: 16,Issue: 3
Page: 222-231
Authors: E. Basal, T. Ayeni, Q. Zhang, C. Langstraat, P.K. Donahoe, D. Pepin, X. Yin, E. Leof and W. Cliby

Evolution of Chemosensitivity and Resistance Assays as Predictors of Clinical Outcomes in Epithelial Ovarian Cancer Patients

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 30
Page: 4717-4728
Authors: Bradley J. Monk, Thomas J. Herzog and Krishnansu S. Tewari

Targeting Leptin as a Therapeutic Strategy against Ovarian Cancer Peritoneal Metastasis

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17,Issue: 8
Page: 1093-1101
Authors: Xiao Wei, Yi Liu, Cheng Gong, Teng Ji, Xiaoshui Zhou, Taoran Zhang, Dongyi Wan, Sen Xu, Ping Jin, Xin Yang, Xiaoting Li, Ding Ma, Zongyuan Yang* and Qinglei Gao*

Chronic Administration of Single Weekly Paclitaxel in Heavily Pretreated Ovarian Cancer Patients

Journal: Current Medicinal Chemistry
Volume: 11,Issue: 4
Page: 425-428
Authors: Kenji Yamamoto, Shirei Oogi, Hiromi Inoue, Kazuya Kudoh, Tsunekazu Kita and Yoshihiro Kikuchi

Validation of Self-Report of Chest X-Ray Exam at a Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Center

Journal: Reviews on Recent Clinical Trials
Volume: 10,Issue: 3
Page: 194-199
Authors: Lisa H. Gren, Lois E. Lamerato, Patrick Wright and Pamela M. Marcus

Expression, Purification, Crystallization and Preliminary X-Ray Analysis of Human Spindlin1, an Ovarian Cancer-Related Protein

Journal: Protein & Peptide Letters
Volume: 13,Issue: 2
Page: 203-205
Authors: Fuguo Jiang, Qiang Zhao, Lipeng Qin, Hai Pang, Xuetao Pei and Zihe Rao

“Metabolic Reprogramming” in Ovarian Cancer Cells Resistant to Cisplatin

Journal: Current Cancer Drug Targets
Volume: 11,Issue: 2
Page: 226-235
Authors: M. Montopoli, M. Bellanda, F. Lonardoni, E. Ragazzi, P. Dorigo, G. Froldi, S. Mammi and L. Caparrotta


Stem Cells in Adult Human Ovaries: From Female Fertility to Ovarian Cancer

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 3
Page: 283-292
Authors: Irma Virant-Klun, Martin Stimpfel and Thomas Skutella

Editorial: Advances in Epithelial Ovarian Cancer Therapy

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 25
Page: 3735-3740
Authors: Judith R. Kroep

Editorial (Thematic Issue: Current Overview of Anti-Angiogenic Therapies for Patients with Epithelial Ovarian Cancer)

Journal: Current Angiogenesis (Discontinued)
Volume: 3,Issue: 4
Page: 175-178
Authors: Samir A. Farghaly

Editorial (Thematic Issue The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial: The Operations Behind a Herculean Task)

Journal: Reviews on Recent Clinical Trials
Volume: 10,Issue: 3
Page: 172-172
Authors: Pamela M. Marcus

Overcoming Chemotherapy Resistance in High Grade Serous Ovarian Cancer

Journal: Current Cancer Therapy Reviews
Volume: 12,Issue: 1
Page: 23-36
Authors: Raghav Sundar, David Tan, Lim S. Lei and Whay-Kuang Chia

Changes in and Impact of the Death Review Process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial

Journal: Reviews on Recent Clinical Trials
Volume: 10,Issue: 3
Page: 206-211
Authors: Anthony B. Miller, Ronald Feld, Robert Fontana, John K. Gohagan, Ismail Jatoi, Walter Lawrence Jr., Amy Miller, Philip C. ProroK, Ashwani Rajput, Morris Sherman, Gilbert Welch, Patrick Wright, Susan Yurgalevitch and Peter Albertsen

Treatment of High-Grade Pelvic-Type Serous Carcinomas (Ovary, Fallopian Tube and Peritoneum): Current Therapeutic Paradigms, Prospects, and Challenges

Journal: Current Cancer Therapy Reviews
Volume: 11,Issue: 4
Page: 300-313
Authors: Mary Chu, D. Stave Kohtz, Estrelania Williams, Tamara Kalir and David Fishman

Synthesis and Pharmacology of New Camptothecin Drugs

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 5,Issue: 5
Page: 425-439
Authors: Russell W. Driver and Li-Xi Yang

Current Treatment of Relapsed Ovarian Carcinoma

Journal: Current Cancer Therapy Reviews
Volume: 2,Issue: 3
Page: 211-221
Authors: Aristotle Bamias, Alexandros Rodolakis and Meletios A. Dimopoulos

The Immunohistochemical Expression of the E-Cadherin, Alpha-Catenin,Beta-Catenin and Gamma Catenin Proteins in Epithelial Ovarian Tumours: Relationship with Clinicopathologic Parameters and Patient Survival

Journal: Current Women`s Health Reviews
Volume: 4,Issue: 2
Page: 93-101
Authors: Faleiro-Rodrigues Cristina, Macedo-Pinto Isabel and Pereira Deolinda

Endometriosis and Gynecological Cancer

Journal: Current Women`s Health Reviews
Volume: 8,Issue: 2
Page: 150-157
Authors: Mihai Emil Capilna, Bela Szabo, Lucian Puscasiu, Aron Toma and Cosmin Rugina

Too Much of a Good Thing: Suicide Prevention Promotes Chemoresistance in Ovarian Carcinoma

Journal: Current Cancer Drug Targets
Volume: 10,Issue: 6
Page: 575-583
Authors: K. Pennington, H. Pulaski, M. Pennington and J.R. Liu

What are the Cancer Risks in BRCA Carriers Apart from Those Regarding the Breast and the Ovary?

Journal: Current Women`s Health Reviews
Volume: 8,Issue: 1
Page: 65-71
Authors: F. Di Gaudio, V. Calo, L. La Paglia, L. Bruno, F. Di Piazza, N. Margarese, F. P. Guadagna, G. Guarneri, G. Cicero, G. R. Ricciardi, C. Rolfo Cervetto, G. Cucinella, G. Pantuso, V. Bazan and A. Russo

The Role of PARP Inhibitors in the Treatment of Ovarian Carcinomas

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 25
Page: 3770-3774
Authors: Anna V. Tinker and Karen Gelmon

The Impact of Proteomics in the Understanding of the Molecular Basis of Paclitaxel-Resistance in Ovarian Tumors

Journal: Current Cancer Drug Targets
Volume: 12,Issue: 8
Page: 987-997
Authors: D. Vergara, A. Tinelli, A. Iannone and M. Maffia

PLCO: Evolution of an Epidemiologic Resource and Opportunities for Future Studies

Journal: Reviews on Recent Clinical Trials
Volume: 10,Issue: 3
Page: 238-245
Authors: Amanda Black, Wen-Yi Huang, Patrick Wright, Tom Riley, Jerome Mabie, Sunitha Mathew, Lawrence Ragard, Sigurd Hermansen, Kelly Yu, Paul Pinsky, Philip C. Prorok, Neal D. Freedman and Robert N. Hoover

Synthesis and Antitumor Activity of 2-Aryl-1, 2, 4-Triazolo[1, 5-a] Pyridine Derivatives

Journal: Medicinal Chemistry
Volume: 6,Issue: 2
Page: 65-69
Authors: Xuefen Tao and Yongzhou Hu

Molecular Targets of Ovarian Carcinomas with Acquired Resistance to Platinum/Taxane Chemotherapy

Journal: Current Cancer Drug Targets
Volume: 6,Issue: 3
Page: 207-227
Authors: Christian Kurzeder, Georg Sauer and Helmut Deissler

Anatomic Site-Related Expression of Cancer-Associated Molecules in Ovarian Carcinoma

Journal: Current Cancer Drug Targets
Volume: 7,Issue: 1
Page: 109-120
Authors: Ben Davidson

Prophylactic Surgery to Reduce the Risk of Developing Breast Cancer:Issues and Clinical Implications

Journal: Current Women`s Health Reviews
Volume: 8,Issue: 1
Page: 94-103
Authors: Elisabetta Razzaboni, Giovanni Tazzioli, Alessia Andreotti, Elisabetta De Matteis, Laura Cortesi and Massimo Federico

Synthesis and Activity of [{Cis-PtCl(NH3)2}2µ{Trans-Pt(3-Hydroxypyridine)2(H2N(CH2)6NH2)2}]Cl4 in the Human Ovarian Tumour Models.

Journal: Medicinal Chemistry
Volume: 8,Issue: 3
Page: 384-391
Authors: Shahnaz AH Hamad, Philip Beale, Jun Qing Yu, Keith Fisher and Fazlul Huq

Inducing Synthetic Lethality using PARP Inhibitors

Journal: Current Clinical Pharmacology
Volume: 5,Issue: 3
Page: 192-195
Authors: David S. Boss, Jos H. Beijnen and Jan H.M. Schellens

Class III β -Tubulin (TUBB3): More than a Biomarker in Solid Tumors?

Journal: Current Molecular Medicine
Volume: 11,Issue: 9
Page: 726-731
Authors: M. Mariani, S. Shahabi, S. Sieber, G. Scambia and C. Ferlini

Synthesis and Evaluation of Biological Activities of a Series of (6-substitutedbenzothiazol-2-yl)acrylamides

Journal: Medicinal Chemistry
Volume: 7,Issue: 6
Page: 727-731
Authors: Nguyen-Hai Nam, Phan Thi Phuong Dung, Doan Thanh Hieu, Le Hoang, Tran Thi Hien, Tran The Cuong and Phan Dinh Chau

Role of microRNAs in Gynecological Pathology

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 15
Page: 2406-2413
Authors: J. Gilabert-Estelles, A. Braza-Boils, L. A. Ramon, E. Zorio, P. Medina, F. Espana and A. Estelles

New Adamantane Derivatives with Sigma Affinity and Antiproliferative Activity

Journal: Medicinal Chemistry
Volume: 8,Issue: 4
Page: 569-586
Authors: Stefanos Riganas, Ioannis Papanastasiou, George B. Foscolos, Andrew Tsotinis, Kostas Dimas, Vassilios N. Kourafalos, Andreas Eleutheriades, Vassilios I. Moutsos, Humaira Khan, Prassa Margarita, Stavroula Georgakopoulou, Angeliki Zaniou, Maria Theodoropoulou, Athanasios Mantelas, Stavroula Pondiki and Alexandre Vamvakides

Taxol: Efficacy Against Oral Squamous Cell Carcinoma

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 13,Issue: 4
Page: 509-521
Authors: Kaitlyn Ledwitch, Ryenne Ogburn, Jodi Cox, Rebekah Graham, Allison Fritzsche, Donna Gosnell and Thomas Manning

Synthesis and Stereochemistry-Activity Relationship of Chiral Thiourea Derivatives as Potential Anticancer Agents

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14,Issue: 6
Page: 910-920
Authors: Vikas Kumar, Akshay Kumar, Vommina V. Sureshbabu and Swapandeep S. Chimni

Role of Farletuzumab in Epithelial Ovarian Carcinoma

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 25
Page: 3812-3815
Authors: Danijela Jelovac and Deborah K. Armstrong

Crystallographic Study and Biological Evaluation of 1,4-dimethyl-N-alkylcarbazoles†

Journal: Current Topics in Medicinal Chemistry
Volume: 15,Issue: 11
Page: 973-979
Authors: Carmela Saturnino, Anna Caruso, Pasquale Longo, Anna Capasso, Attilio Pingitore, Maria Cristina Caroleo, Erika Cione, Mariarita Perri, Francesco Nicolo, Viviana Mollica Nardo, Luigi Monsu Scolaro, Maria Stefania Sinicropi, Maria Rosaria Plutino and Hussein El-Kashef

Cytotoxic Molecules from Natural Sources: Tapping the Brazilian Biodiversity

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 6,Issue: 4
Page: 367-375
Authors: Ivana Barbosa Suffredini, Antonio Drauzio Varella and Riad Naim Younes

Paclitaxel Antibody Conjugates and Trehalose for Preserving the Immunulogical Activity After Freeze-Drying

Journal: Current Medicinal Chemistry
Volume: 11,Issue: 4
Page: 439-446
Authors: Jairo Jaime and Michel Page

Preclinical Evaluation of New Taxoids

Journal: Current Pharmaceutical Design
Volume: 7,Issue: 13
Page: 1251-1257
Authors: M. -C. Bissery

Looking at Drug Resistance Mechanisms for Microtubule Interacting Drugs: Does TUBB3 Work?

Journal: Current Cancer Drug Targets
Volume: 7,Issue: 8
Page: 704-712
Authors: Cristiano Ferlini, Giuseppina Raspaglio, Lucia Cicchillitti, Simona Mozzetti, Silvia Prislei, Silvia Bartollino and Giovanni Scambia

Clinical Trials of Targeted Alpha Therapy for Cancer

Journal: Reviews on Recent Clinical Trials
Volume: 3,Issue: 3
Page: 185-191
Authors: Barry J. Allen

BRCA1 and BRCA2 Molecular Testing in Women with Different Risk of Hereditary Breast Cancer: ost/Effectiveness and Psychological Implications

Journal: Current Women`s Health Reviews
Volume: 8,Issue: 1
Page: 12-16
Authors: Liborio Stuppia

Anti-cancer Scopes and Associated Mechanisms of Scutellaria Extract and Flavonoid Wogonin

Journal: Current Cancer Therapy Reviews
Volume: 9,Issue: 1
Page: 34-42
Authors: Paras S. Patel, Nirmal Joshee, Agnes M. Rimando and Prahlad Parajuli

Tumor Marker Detection by Aptamer-Functionalized Graphene Oxide

Journal: Current Organic Chemistry
Volume: 17,Issue: 2
Page: 132-136
Authors: Ming-Yu Lin, Yen-Pei Lu, Alexandru M. Grumezescu, Fu H. Ho, Ying-Hsien Kao, Yuh-Shyong Yang and Chih-Hui Yang

Biomedical Hypothesis Generation by Text Mining and Gene Prioritization

Journal: Protein & Peptide Letters
Volume: 21,Issue: 8
Page: 847-857
Authors: Ingrid Petric, Balazs Ligeti, Balazs Gyorffy and Sandor Pongor

Aldose Reductase: A Multi-disease Target

Journal: Current Enzyme Inhibition
Volume: 10,Issue: 1
Page: 2-12
Authors: Jaiprakash N. Sangshetti, Rashmi S. Chouthe, Nikhil S. Sakle, Indrajeet Gonjari and Devanand B. Shinde

Caspases and ROS - Dependent Mechanism of Action Mediated by Combination of WP 631 and Epothilone B

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14,Issue: 9
Page: 1261-1270
Authors: Aneta Rogalska, Barbara Bukowska and Agnieszka Marczak

Synthesis and Biological Evaluation of the Salicylamide and Salicylic Acid Derivatives as Anti-Estrogen Agents

Journal: Medicinal Chemistry
Volume: 8,Issue: 3
Page: 481-490
Authors: Yasemin Dundar, Yasemin Ozatik, Orhan Ozatik, Volkan Ergin, Tijen Onkol, Adnan Menevse, Kevser Erol and M. Fethi Sahin

Challenges in Diagnosis of Reproductive Dysfunction

Journal: Current Women`s Health Reviews
Volume: 2,Issue: 2
Page: 145-153
Authors: Tarala D. Nandedkar

Pharmacology of Topoisomerase I Inhibitors Irinotecan (CPT-11) and Topotecan

Journal: Current Cancer Drug Targets
Volume: 2,Issue: 2
Page: 103-123
Authors: Ron H.J. Mathijssen, Walter J. Loos, Jaap Verweij and Alex Sparreboom

A Prevention Strategy for Circumventing Drug Resistance in Cancer Chemotherapy

Journal: Current Pharmaceutical Design
Volume: 7,Issue: 16
Page: 1595-1614
Authors: Gerald D. Frenkel and Paula B. Caffrey

Immunology of Gynecologic Neoplasms: Analysis of the Prognostic Significance of the Immune Status

Journal: Current Cancer Drug Targets
Volume: 9,Issue: 4
Page: 541-565
Authors: F. Bellati, V. Visconti, C. Napoletano, M. Antonilli, L. Frati, P. Benedetti Panici and M. Nuti

Targeting Angiogenesis in Ovarian Carcinoma

Journal: Current Cancer Therapy Reviews
Volume: 5,Issue: 3
Page: 188-202
Authors: Marta Mendiola, Jorge Barriuso and David Hardisson

Breastfeeding and Diabetes

Journal: Current Diabetes Reviews
Volume: 7,Issue: 2
Page: 135-142
Authors: E. Gouveri, N. Papanas, A. I. Hatzitolios and E. Maltezos

Role of the Renin-Angiotensin System in Gynecologic Cancers

Journal: Current Cancer Drug Targets
Volume: 11,Issue: 4
Page: 405-411
Authors: K. Ino, K. Shibata, E. Yamamoto, H. Kajiyama, A. Nawa, Y. Mabuchi, S. Yagi, S. Minami, Y. Tanizaki, A. Kobayashi and F. Kikkawa

Ovulation Inducing Agents and Cancer Risk: Review of Literature

Journal: Current Drug Safety
Volume: 6,Issue: 4
Page: 250-258
Authors: Gianna Gabriella Impicciatore and Gian Mario Tiboni

Application of RNA Interference for the Control of Female Reproductive Functions

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 3
Page: 325-336
Authors: Alexander V. Sirotkin

New Cathepsin D Inhibitorswith Hydroxyethylamine Isosteres: Preparation and Characterization

Journal: Medicinal Chemistry
Volume: 2,Issue: 1
Page: 27-38
Authors: S. E. Hatfield, W. E. Godwin, K. Sayyar, J. F. Lindley, A. W. Green, C. J. Trana, M. S. McConnell and R. M. McConnell

Development and Current Status of Unconventional Platinum Anticancer Complexes

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 7,Issue: 2
Page: 203-211
Authors: Adnan Salim Abu-Surrah

Molecular Rationales for Signal Transduction Therapy and Chemoprevention of BRCA1-Related Breast and Ovarian Tumours

Journal: Current Signal Transduction Therapy
Volume: 2,Issue: 2
Page: 165-173
Authors: P. Tagliaferri, P. Tassone, A. Pietragalla, M. S. Rotundo, V. Barbieri, A. Budillon, M. Caraglia, F. S. Costanzo and S. Venuta

Rationale for an Intraperitoneal Gemcitabine Chemotherapy Treatment for Patients with Resected Pancreatic Cancer

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 4,Issue: 2
Page: 174-179
Authors: Anil Kamath, Dal Yoo, Oswald A. Stuart, Lana Bijelic and Paul H. Sugarbaker

Surgical Strategies for Fertility Preservation in Women with Cancer

Journal: Current Women`s Health Reviews
Volume: 6,Issue: 2
Page: 167-176
Authors: Mohamed A. Bedaiwy, Kristine Zanotti, Ahmed Y. Shahin, Mohamed Yahya Abdel Rahman and William W. Hurd

Targeting Cancer Stem Cell Lines as a New Treatment of Human Cancer

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 5,Issue: 3
Page: 205-218
Authors: Domenica Giuffrida and Ian M. Rogers

Studies on Two New Mixed Ligand Platinum Compounds with a Trans- Geometry

Journal: Medicinal Chemistry
Volume: 6,Issue: 5
Page: 321-328
Authors: Jehad Al-Shuneigat, Jun Qing Yu, Philip Beale, Keith Fisher and Fazlul Huq

Differential Serum Level of Specific Haptoglobin Isoforms in Small Cell Lung Cancer

Journal: Current Proteomics
Volume: 7,Issue: 1
Page: 49-56
Authors: Ankur Shah, Harpreet Singh, Vibhu Sachdev, James Lee, Sohiya Yotsukura, Ravi Salgia and Ajit Bharti

Chemopreventive Properties of Indole-3-Carbinol, Diindolylmethane and Other Constituents of Cardamom Against Carcinogenesis

Journal: Recent Patents on Food, Nutrition & Agriculture
Volume: 2,Issue: 2
Page: 166-177
Authors: Asha Acharya, Ila Das, Sushmita Singh and Tapas Saha

Vitamin D, Sunlight and Cancer Connection

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13,Issue: 1
Page: 70-82
Authors: Michael F. Holick

The Tribbles-1 Protein in Humans: Roles and Functions in Health and Disease

Journal: Current Molecular Medicine
Volume: 13,Issue: 1
Page: 80-85
Authors: E. Dugast, E. Kiss-Toth, J.-P. Soulillou, S. Brouard and J. Ashton-Chess

The Role of Mesothelin in Tumor Progression and Targeted Therapy

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13,Issue: 2
Page: 276-280
Authors: Zhewei Tang, Min Qian and Mitchell Ho

Aflibercept: A Novel VEGF Targeted Agent to Explore the Future Perspectives of Anti-Angiogenic Therapy for the Treatment of Multiple Tumors

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 13,Issue: 4
Page: 530-540
Authors: Tina Sharma, Richa Dhingra, Sukhminder Singh, Shivani Sharma, Prince Tomar, Manav Malhotra and T. R. Bhardwaj

Past, Present and Future Strategies of Immunotherapy in Gynecological Malignancies

Journal: Current Molecular Medicine
Volume: 13,Issue: 4
Page: 648-669
Authors: F. Bellati, C. Napoletano, I. Ruscito, V. Visconti, M. Antonilli, M.L. Gasparri, I.G. Zizzari, H. Rahimi, I. Palaia, A. Rughetti, P. Benedetti Panici and M. Nuti

Commercial Opportunities and Ethical Pitfalls in Personalized Medicine: A Myriad of Reasons to Revisit the Myriad Genetics Saga

Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 11,Issue: 2
Page: 98-109
Authors: Derek So and Yann Joly

The Anti-Oxidant Properties of Isothiocyanates: A Review

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 7,Issue: 3
Page: 213-225
Authors: Sônia M. de Figueiredo, Sidney A.V. Filho, José A. Nogueira-Machado and Rachel B. Caligiorne

Synthesis and Anti-tumor Activity Evaluation of Gallic Acid-mangiferin Hybrid Molecule

Journal: Medicinal Chemistry
Volume: 9,Issue: 8
Page: 1058-1062
Authors: Xiang-yu Hu, Jia-gang Deng, Lin Wang and Ye-fei Yuan

Update on Statins: Hope for Osteoporotic Fracture Healing Treatment

Journal: Current Drug Targets
Volume: 14,Issue: 13
Page: 1524-1532
Authors: Nurul ‘Izzah Ibrahim, Norazlina Mohamed and Ahmad Nazrun Shuid

In Vitro, In Vivo and In Silico Analysis of the Anticancer and Estrogen-like Activity of Guava Leaf Extracts

Journal: Current Medicinal Chemistry
Volume: 21,Issue: 20
Page: 2322-2330
Authors: L.Y. Rizzo, G.B. Longato, A.LT.G. Ruiz, S.V. Tinti, A. Possenti, D.B. Vendramini-Costa, A. Sartoratto, G.M. Figueira, F.L.N. Silva, M.N. Eberlin, T.A.C.B. Souza, M.T. Murakami, E. Rizzo, M.A. Foglio, F. Kiessling, T. Lammers and J.E. Carvalho

Ovarian Toxicity: From Environmental Exposure to Chemotherapy

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 34
Page: 5388-5397
Authors: Roberto Iorio, Annalisa Castellucci, Giovanni Ventriglia, Flavia Teoli, Valerio Cellini, Guido Macchiarelli and Sandra Cecconi

SPARC in Tumor Pathophysiology and as a Potential Therapeutic Target

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 39
Page: 6182-6190
Authors: Jianguo Feng and Liling Tang

A Novel Multiple Tyrosine-kinase Targeted Agent to Explore the Future Perspectives of Anti-Angiogenic Therapy for the Treatment of Multiple Solid Tumors: Cabozantinib

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15,Issue: 1
Page: 37-47
Authors: Subhajit Roy, Bawneet K. Narang, Shiva K. Rastogi and Ravindra K. Rawal

Thiosemicarbazone-Pt(II) Complex Causes a Growth Inhibitory Effect on Human Mesenchymal Stem Cells

Journal: Medicinal Chemistry
Volume: 11,Issue: 7
Page: 670-675
Authors: Josefa Predestinacion Garcia-Ruiz, Ana Isabel Matesanz Garcia, Ana Perez Souza and Pilar Souza Castelo

Management of Fallopian Tube Cancer

Journal: Reviews on Recent Clinical Trials
Volume: 10,Issue: 4
Page: 276-281
Authors: Shweta Rai and Amita Maheshwari

Development of Crystalline Cellulosic Fibres for Sustained Release of Drug

Journal: Current Topics in Medicinal Chemistry
Volume: 16,Issue: 18
Page: 2026-2035
Authors: D. Mishra, V. Yadav, Puja Khare, Jyotshna, M. R. Das, Abha Meena and K. Shanker

Role of Colloidal Drug Delivery Carriers in Taxane-mediated Chemotherapy: A Review

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 33
Page: 5127-5143
Authors: Pramod Kumar, Kaisar Raza, Lokesh Kaushik, Ruchi Malik, Shweta Arora and Om Prakash Katare

Synthesis and Evaluation of Anticancer Activity of 5-Ylidene-4- Aminothiazol-2(5H)-one Derivatives

Journal: Medicinal Chemistry
Volume: 11,Issue: 6
Page: 517-530
Authors: Danylo Kaminskyy, Ivanna Subtel’na, Borys Zimenkovsky, Olexandr Karpenko, Andrzej Gzella and Roman Lesyk

Oncogenic Role of SET/I2PP2A for Gynecologic Cancers

Journal: Current Drug Targets
Volume: 18,Issue: 10
Page: 1152-1157
Authors: Shi-wen Jiang, Siliang Xu, Haibin Chen, Jiayin Liu* and Ping Duan

Synthesis, Antioxidant, Anticancer and Antiviral Activities of Novel Quinoxaline Hydrazone Derivatives and their Acyclic C-Nucleosides

Journal: Medicinal Chemistry
Volume: 10,Issue: 5
Page: 521-532
Authors: Alaa A. El-Tombary and Soad A.M. El-Hawash

Comprehensive Quality Management (CQM) in the PLCO Trial

Journal: Reviews on Recent Clinical Trials
Volume: 10,Issue: 3
Page: 223-232
Authors: John K. Gohagan, Barbara O’Brien, Marsha A. Hasson, Keith D. Umbel, Beth Bridgeman, Barnett S. Kramer, Douglas Reding, Lisa Gren, Patrick Wright, Thomas Riley and Philip C. Prorok

Lessons in Medical Record Abstraction from the Prostate, Lung, Colorectal, and Ovarian (PLCO) National Screening Trial

Journal: Reviews on Recent Clinical Trials
Volume: 10,Issue: 3
Page: 200-205
Authors: Bazzi Latifa, Lamerato Lois E, Varner Julie, Shambaugh Vicki L., Cordes Jill E, Ragard Lawrence R and Marcus Pamela M

Choline Kinase: An Important Target for Cancer

Journal: Current Medicinal Chemistry
Volume: 13,Issue: 10
Page: 1169-1186
Authors: S. Janardhan, P. Srivani and G. N. Sastry

Angiogenesis Inhibitors: Perspectives for Medical, Surgical and Radiation Oncology

Journal: Current Pharmaceutical Design
Volume: 12,Issue: 21
Page: 2623-2630
Authors: C. Verhoef, J. H.W. de Wilt and H. M.W. Verheul

Physical Activity and Cancer Prevention: Updating the Evidence. The Role of Oxidative Stress in Carcinogenesis

Journal: Current Cancer Therapy Reviews
Volume: 3,Issue: 2
Page: 81-95
Authors: Joanna Kruk and Hassan Y. Aboul-Enein

Small Molecules with EGFR-TK Inhibitor Activity

Journal: Current Drug Targets
Volume: 6,Issue: 3
Page: 259-274
Authors: Joan Albanell and Pere Gascon

Changes in the Apoptotic and Survival Signaling in Cancer Cells and Their Potential Therapeutic Implications

Journal: Current Cancer Drug Targets
Volume: 4,Issue: 2
Page: 147-163
Authors: Albert F. Kabore, James B. Johnston and Spencer B. Gibson

Recent Advances in the Identification of Genetic and Biochemical Components of Breast Cancer Predisposition

Journal: Current Genomics
Volume: 3,Issue: 5
Page: 389-412
Authors: M. K. Sauer

Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1

Journal: Current Medicinal Chemistry
Volume: 15,Issue: 2
Page: 137-150
Authors: S. Gobec, P. Brozic and T. Lanisnik Rizner

Comparative Binding Analysis of Monoclonal Antibodies Against Native and Mutant Type in ErbB2 Receptor: A Theoretical Modeling Approach

Journal: Current Pharmaceutical Biotechnology
Volume: 10,Issue: 7
Page: 701-708
Authors: R. Rajasekaran and Sethumadhavan Rao

Differences and Similarities of Epothilones

Journal: Current Cancer Therapy Reviews
Volume: 7,Issue: 1
Page: 10-36
Authors: Werner Krause and Ulrich Klar

Carcinoma of the Lower Uterine Segment (LUS): Clinicopathological Characteristics and Association with Lynch Syndrome

Journal: Current Genomics
Volume: 12,Issue: 1
Page: 25-29
Authors: Kenta Masuda, Kouji Banno, Megumi Yanokura, Yusuke Kobayashi, Iori Kisu, Arisa Ueki, Asuka Ono, Hiroyuki Nomura, Akira Hirasawa, Nobuyuki Susumu and Daisuke Aoki

Dasatinib: An Anti-Tumour Agent via Src Inhibition

Journal: Current Drug Targets
Volume: 12,Issue: 4
Page: 563-578
Authors: Antonio Gnoni, Ilaria Marech, Nicola Silvestris, Angelo Vacca and Vito Lorusso

Future Prospects for Old Chemotherapeutic Drugs in the Target-Specific Era; Pharmaceutics, Combinations, Co-Drugs and Prodrugs with Melphalan as an Example

Journal: Letters in Drug Design & Discovery
Volume: 3,Issue: 10
Page: 695-703
Authors: M. Wickstrom, H. Lovborg and J. Gullbo

Malignant Pleural Effusions: Review of Treatment and Our Experience

Journal: Reviews on Recent Clinical Trials
Volume: 2,Issue: 1
Page: 21-25
Authors: L. Bertolaccini, C. Zamprogna, L. Barberis, M. Navarra, E. Manno, A. D, ’, Urso and F. Massaglia

The Endothelin Axis: A Novel Target for Pharmacotherapy of Female Malignancies

Journal: Current Vascular Pharmacology
Volume: 5,Issue: 3
Page: 239-248
Authors: Martin Smollich and Pia Wulfing

Synthesis, Activity and Binding with DNA of [{trans-PtCl(NH ) }2μ-{trans- Pd(4-hydroxypyridine) (H N(CH ) NH ) ]Cl (TH8)

Journal: Medicinal Chemistry
Volume: 5,Issue: 4
Page: 372-381
Authors: Fazlul Huq, Hasan Tayyem, Jun Qing Yu, Philip Beale and Keith Fisher

Studies on Synthesis, Activity and Binding with DNA of a New Trinuclear Platinum Compound [{trans-PtCl(NH3)2}2{trans-Pt(thiazole)2}{H2N(CH2)6 NH2}2]Cl3(NO3)

Journal: Medicinal Chemistry
Volume: 7,Issue: 1
Page: 1-8
Authors: Jehad Al-Shuneigat, Yu Qing, Philip Beale, Keith Fisher and Fazlul Huq

Characterization of Molecular Alterations of BRCA1/2: Analysis and Interpretation Guidelines

Journal: Current Women`s Health Reviews
Volume: 8,Issue: 1
Page: 4-11
Authors: Daniele Calistri, Valentina Zampiga and Wainer Zoli

Opportunities of Finding Novel Anti-Infective Agents from Plant Cell Cultures

Journal: Current Medicinal Chemistry -Anti-Infective Agents
Volume: 2,Issue: 3
Page: 191-211
Authors: Ishrak Khafagi, Ahmed Dewedar and Mahamoud Amein

Recent Progress and Future Potential for Metal Complexes as Anticancer Drugs Targeting G-quadruplex DNA

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 18
Page: 2957-2975
Authors: J. Zhang, F. Zhang, H. Li, C. Liu, J. Xia, L. Ma, W. Chu, Z. Zhang, C. Chen, S. Li and S. Wang

Animal Modeling of Cancer Pathology and Studying Tumor Response to Therapy

Journal: Current Drug Targets
Volume: 13,Issue: 12
Page: 1535-1547
Authors: Simon P. Langdon

State-of-the-Art Magnetic Resonance Spectroscopy in Oncologic Imaging

Journal: Current Molecular Imaging (Discontinued)
Volume: 2,Issue: 1
Page: 53-65
Authors: Natalie J. Serkova

Relations between GPR4 Expression, Microvascular Density (MVD) and Clinical Pathological Characteristics of Patients with Epithelial Ovarian Carcinoma (EOC)

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 11
Page: 1904-1916
Authors: Juan Ren, Wen Jin, Yan-e Gao, Yuelang Zhang, Xiaozhi Zhang, Dongli Zhao, Hongbing Ma, Zongfang Li, Jiansheng Wang, Lisha Xiao, Rui Liu, Yuanyuan Chen, Jiansheng Qian, liying Niu, Hongxia Wei and Yan Liu

Resistance to Peloruside A and Laulimalide: Functional Significance of Acquired βI-tubulin Mutations at Sites Important for Drug-Tubulin Binding

Journal: Current Cancer Drug Targets
Volume: 14,Issue: 1
Page: 79-90
Authors: Arun Kanakkanthara, Jonathan Eras, Peter T. Northcote, Fernando Cabral and John H. Miller

A Systemic Approach to Cancer Treatment: Tumor Cell Reprogramming Focused on Endocrine-Related Cancers

Journal: Current Medicinal Chemistry
Volume: 21,Issue: 9
Page: 1072-1081
Authors: P.M. Biava, A. Nicolini, P. Ferrari, A. Carpi and S. Sell

ROS1 Kinase Inhibitors for Molecular-Targeted Therapies

Journal: Current Medicinal Chemistry
Volume: 23,Issue: 2
Page: 142-160
Authors: M.M. Al-Sanea, A.Z. Abdelazem, B.S. Park, K.H. Yoo, T. Sim, Y.J. Kwon and S.H. Lee

Targeting of Peptide Cytotoxins to LHRH Receptors For Treatment of Cancer

Journal: Current Drug Targets
Volume: 17,Issue: 5
Page: 488-494
Authors: Jorg B. Engel, Hans-Rudolf Tinneberg, Ferenc G. Rick, Enniko Berkes and Andrew V. Schally

Phytochemicals as Adjunctive with Conventional Anticancer Therapies

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 27
Page: 4201-4218
Authors: Mohammad Hosein Farzaei, Roodabeh Bahramsoltani and Roja Rahimi

Noscapine and its Analogs as Chemotherapeutic Agent: Current updates

Journal: Current Topics in Medicinal Chemistry
Volume: 17,Issue: 2
Page: 174-188
Authors: Vartika Tomar, Shrikant Kukreti, Satya Prakash, Jitender Madan and Ramesh Chandra

Propagation on Molecular Interaction Networks: Prediction of Effective Drug Combinations and Biomarkers in Cancer Treatment

Journal: Current Pharmaceutical Design
Volume: 23,Issue: 1
Page: 5-28
Authors: Balazs Ligeti, Otilia Menyhart, Ingrid Petric, Balazs Gyorffy and Sandor Pongor

Synthesis, Antitubercular and Anticancer Activities of p-nitrophenylethylenediamine- Derived Schiff Bases

Journal: Medicinal Chemistry
Volume: 13,Issue: 4
Page: 391-397
Authors: Raquel S. Amim, Claudia Pessoa, Maria C. S. Lourenco, Marcus V. N. de Souza and Josane A. Lessa*

Data Processing and Analytic Support in the PLCO Cancer Screening Trial

Journal: Reviews on Recent Clinical Trials
Volume: 10,Issue: 3
Page: 233-237
Authors: Jerome Mabie, Tom Riley, Pamela M. Marcus, Amanda Black, Heather Rozjabek, Kelly Yu, Michael Young, Joe Austin, Josh Rathmell, Craig Williams and Philip C. Prorok

Building Successful Relationships in the PLCO Cancer Screening Trial

Journal: Reviews on Recent Clinical Trials
Volume: 10,Issue: 3
Page: 181-186
Authors: Pamela M. Marcus, Karen G. Broski, Saundra S. Buys, Jeffery Childs, Timothy R. Church, John K. Gohagan, Lisa H. Gren, Darlene Higgins, Rachel Jaggi, Victoria Jenkins, Christine C. Johnson, Karen Lappe, Barbara O’Brien, Sheryl L. Ogden, Philip C. Prorok, Douglas Reding, Vicki Shambaugh, Lance A. Yokochi and Susan Yurgalevitch

The PLCO Biorepository: Creating, Maintaining, and Administering a Unique Biospecimen Resource

Journal: Reviews on Recent Clinical Trials
Volume: 10,Issue: 3
Page: 212-222
Authors: Danielle M. Carrick, Amanda Black, John K. Gohagan, Asia Khan, Karen Pettit, Craig Williams, Kelly Yu, Susan Yurgalevitch, Wen-Yi Huang and Claire Zhu

Gonadotropin-Releasing Hormone (GnRH) Receptors in Tumors: a New Rationale for the Therapeutical Application of GnRH Analogs in Cancer Patients?

Journal: Current Cancer Drug Targets
Volume: 6,Issue: 3
Page: 257-269
Authors: M. M. Marelli, R. M. Moretti, J. Januszkiewicz-Caulier, M. Motta and P. Limonta

Nanoparticles of Biodegradable Polymers for Clinical Administration of Paclitaxel

Journal: Current Medicinal Chemistry
Volume: 11,Issue: 4
Page: 413-424
Authors: Si-Shen Feng, Li Mu, Khin Yin Win and Guofeng Huang

Should the Status of the Pathway Mediated by BRCA1 and BRCA2 be Evaluated Before Selecting Cancer Chemotherapy Drugs?

Journal: Current Pharmacogenomics
Volume: 5,Issue: 4
Page: 280-291
Authors: Bernard Friedenson

In Vitro and In Vivo Biodistribution of ZRS1, a Stabilized Type I N-Acetoxymethyl Carbamate-Containing Combi-Molecule

Journal: Drug Metabolism Letters
Volume: 5,Issue: 2
Page: 141-149
Authors: Nahid Golabi, Zakaria Rachid, Qiyu Qiu, Ying Huang and Bertrand J. Jean-Claude

Lynch Syndrome: Awareness among Medical Students at a United States Medical School

Journal: Current Women`s Health Reviews
Volume: 8,Issue: 3
Page: 242-247
Authors: Melissa K. Frey, Mollie A. Biewald, Michael J. Worley, Jolyn S. Taylor, Stephanie N. Lin and Kevin Holcomb

Identification and Usage of Fluorescent Probes as Nanoparticle Contrast Agents in Detecting Cancer

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 25
Page: 4622-4640
Authors: Manikanta Swamy Murahari and Mayur C. Yergeri

Quality Survival with Fertility after Gynaecological and other Cancers

Journal: Current Women`s Health Reviews
Volume: 12,Issue: 2
Page: 115-125
Authors: Shakuntala A. Chhabra

Combination Platinum-based and DNA Damage Response-targeting Cancer Therapy: Evolution and Future Directions

Journal: Current Medicinal Chemistry
Volume: 24,Issue: 15
Page: 1586-1606
Authors: Spyridon P. Basourakos, Likun Li, Ana M. Aparicio, Paul G. Corn, Jeri Kim and Timothy C. Thompson*

Design, Synthesis and Biological Evaluation of a Phenyl Butyric Acid Derivative, N-(4-chlorophenyl)-4-phenylbutanamide: A HDAC6 Inhibitor with Anti-proliferative Activity on Cervix Cancer and Leukemia Cells

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17,Issue: 10
Page: 1441-1454
Authors: Rodriguez-Fonseca Rolando Alberto, Sixto-Lopez Yudibeth, Fragoso-Vazquez M. Jonathan, Flores-Mejia Raul, Cabrera-Perez Laura Cristina, Vazquez-Moctezuma Ismael, Rosales-Hernandez Martha Cecilia, Bello Martiniano, Martinez-Archundia M, Trujillo-Ferrara Jose Guadalupe, Becerra-Martinez Elvia and Correa-Basurto Jose*

Update on Screening in Prostate Cancer Based on Recent Clinical Trials

Journal: Reviews on Recent Clinical Trials
Volume: 6,Issue: 1
Page: 7-15
Authors: Alessandro Sciarra, Susanna Cattarino, Stefano Salciccia, Alessandro Gentilucci, Andrea Alfarone, Gianna Mariotti, Michele Innocenzi and Vincenzo Gentile

Molecule of the Month

Journal: Current Topics in Medicinal Chemistry
Volume: 7,Issue: 8
Page: 821-821
Authors: Kari Anne Myers

Editorial Review of 2014

Journal: Current Radiopharmaceuticals
Volume: 7,Issue: 1
Page: 1-4
Authors: Sean L. Kitson and Luigi Mansi

Results 1 - 224 of 224